Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione
- PMID: 7954469
Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione
Abstract
Alkylating agents can be detoxified by conjugation with glutathione (GSH). One of the physiological significances of this lies in the observation that cancer cells resistant to the cytotoxic effects of alkylating agents have higher levels of GSH and high glutathione S-transferase (GST) activity. However, little is known about the GSH-/GST-dependent biotransformation of alkylating agents, including cyclophosphamide. Cyclophosphamide becomes cytostatic after the enzymatic formation of 4-hydroxycyclophosphamide. The ultimate alkylating species formed from cyclophosphamide is phosphoramide mustard. In this paper we describe the involvement of purified human glutathione S-transferases isoenzymes GST A1-1, A2-2, M1a-1a, and P1-1 in the formation of two types of glutathionyl conjugates of cyclophosphamide, i.e., 4-glutathionylcyclophosphamide (4-GSCP) and monochloromonoglutathionylphosphoramide mustard. When 0.1 mM 4-hydroxycyclophosphamide and 1 mM GSH was incubated in the presence of 10 microM GST A1-1, A2-2, M1a-1a, and P1-1 the formation of 4-GSCP was 2-4-fold increased above the spontaneous level. Enzyme kinetic analysis demonstrated the lowest Km (0.35 mM) for GST A1-1. Km values for the other GST enzymes ranged from 1.0 to 1.9 mM. Glutathione S-transferase A1-1 (40 microM) also increased the conjugation of phosphoramide mustard and GSH (both 1 mM) 2-fold, while the other major human isoenzymes, A2-2, M1a-1a, and P1-1, did not influence the formation of monochloromonoglutathionylphosphoramide mustard. These results indicate that only one enzyme within the class of human GST alpha enzymes was able to catalyze the reaction of the aziridinium ion of phosphoramide mustard with glutathione. Thus increased levels of GST A1-1 in tumor cells can contribute to an enhanced detoxification of phosphoramide mustard and hence to the development of drug resistance. Since all of the human GSTs tested did catalyze the formation of 4-GSCP, the role of 4-GSCP either as a transport form of activated cyclophosphamide or as a detoxification product is discussed.
Similar articles
-
The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa.Cancer Res. 1995 Apr 15;55(8):1701-6. Cancer Res. 1995. PMID: 7712478
-
Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases.Chem Res Toxicol. 1995 Oct-Nov;8(7):979-86. doi: 10.1021/tx00049a012. Chem Res Toxicol. 1995. PMID: 8555414
-
Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.Drug Metab Dispos. 1991 May-Jun;19(3):625-9. Drug Metab Dispos. 1991. PMID: 1680629
-
[Anti-cancer drug resistance and glutathione S-transferases].Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 2):592-8. Gan To Kagaku Ryoho. 1989. PMID: 2650631 Review. Japanese.
-
Importance of glutathione and associated enzymes in drug response.Oncol Res. 1997;9(6-7):295-302. Oncol Res. 1997. PMID: 9406235 Review.
Cited by
-
Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf.Pharmaceuticals (Basel). 2025 Jun 14;18(6):895. doi: 10.3390/ph18060895. Pharmaceuticals (Basel). 2025. PMID: 40573290 Free PMC article. Review.
-
Glutathione: Lights and Shadows in Cancer Patients.Biomedicines. 2023 Aug 8;11(8):2226. doi: 10.3390/biomedicines11082226. Biomedicines. 2023. PMID: 37626722 Free PMC article. Review.
-
Genetic Polymorphism of GSTP-1 Affects Cyclophosphamide Treatment of Autoimmune Diseases.Molecules. 2020 Mar 28;25(7):1542. doi: 10.3390/molecules25071542. Molecules. 2020. PMID: 32231024 Free PMC article.
-
Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer.Support Care Cancer. 2022 Sep;30(9):7355-7363. doi: 10.1007/s00520-022-07118-y. Epub 2022 May 24. Support Care Cancer. 2022. PMID: 35606478
-
Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women.Breast Cancer Res Treat. 2021 Apr;186(3):823-837. doi: 10.1007/s10549-020-06028-z. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33392841
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials